NCPA to hold annual convention and trade expo this fall in San Diego
ALEXANDRIA, Va. — The National Community Pharmacists Association is slated to host its 114th annual convention and trade exposition this fall in San Diego.
Held Oct. 13 to 17 at the San Diego Convention Center, NCPA said its annual meeting will present the latest in pharmacy education, case studies and real world, business-impacting information for the independent community pharmacy industry and will tout the theme of "Meet. Learn. Succeed.," which reflects the top goals of the meeting for the representatives of more than 3,000 community pharmacies who attend each year. The show also will feature nearly 20 hours of continuing education credits on such topics as marketing, adherence, technology and pharmacy-sustaining niches, including long-term care, immunizations, compounding and more. New this year will be daily non-CE business basics with NCPA senior director of sales and marketing Gabe Trahan, who will lead business breakfast discussions and identify the top five products of the day on the tradeshow floor and help attendees learn how to merchandise them back home in their pharmacies.
The NCPA also said the event’s keynote speaker will be former congressman Joe Scarborough, R-Fla., host of MSNBC’s "Morning Joe."
"We are excited as always to bring practical business and advocacy solutions to community pharmacists, with experts and content to help improve the bottom line," NCPA president and Oklahoma City pharmacy owner Lonny Wilson said. "Our convention programming reflects those values."
Report: Teva changes up leadership of U.S. generics division
JERUSALEM — Teva has shuffled some of its executives in an effort to effectively compete in the U.S. generics market, according to published reports.
The company — which updated its 2012 non-GAAP financial outlook last Thursday to include diluted earnings per share of $5.30 to $5.40, as well as generic product (including API) net sales of approximately $10.7 billion, consisting of U.S. generic sales of $4.6 billion, European generic sales of $3.4 billion, and ROW generic sales of $2.7 billion — said Allan Oberman, who led Teva’s EMIA (Eastern Europe, Israel, the Middle East, and Africa) division, now will lead the U.S. generics division, while the division’s former leader, Tim Crew, is moving to another role in the organization, according to the Philadelphia Inquirer.
The news comes at the heels of former Bristol-Myers Squibb executive Jeremy Levin taking the reins of the generic drug maker.
Click here to read the full story.
Dollar Tree to split common stock 2-to-1
CHESAPEAKE, Va. — Dollar Tree on Tuesday approved a 2-for-1 stock split in the form of a 100% common stock dividend. The new shares will be distributed June 26 for shareholders of record as of the close of business on June 12.
With the stock split, the number of outstanding shares of the company’s common stock will increase from approximately 116 million shares, pre-split, to approximately 232 million shares, post-split.
"Dollar Tree is committed to building value for long-term shareholders," stated Bob Sasser, president and CEO. "The stock dividend announced today is designed to increase the liquidity of the company’s stock and provide a more attractive entry point for shareholders, affording the potential to broaden the shareholder base."
Dollar Tree shares were down slightly by 44 cents to $101.78 in mid-day trading.
Dollar Tree operated 4,451 stores across 48 states and five Canadian provinces as of April 28, with total retail selling square footage of 38.6 million.